ASTRAZENECA PLC (AZN)
Clinical trial NCT06666504 updates: 1. status: NOT_YET_RECRUITING → COMPLETED 2. start date: 2024-12-01 → 2024-12-11 3. completion date: 2026-06-30 → 2026-06-20 4. primary completion date: 2025-12-30 → 2026-06-20 5. enrollment type: ESTIMATED → ACTUAL 6. collaborators added: AstraZeneca
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical